Your browser doesn't support javascript.
loading
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study.
Butzkueven, Helmut; Licata, Stephanie; Jeffery, Douglas; Arnold, Douglas L; Filippi, Massimo; Geurts, Jeroen Jg; Santra, Sourav; Campbell, Nolan; Ho, Pei-Ran.
Afiliação
  • Butzkueven H; Department of Neuroscience, Central Clinical School, Alfred Campus, Monash University, Melbourne, Victoria, Australia.
  • Licata S; Department of Neurology, Box Hill Hospital, Monash University, Box Hill, Victoria, Australia.
  • Jeffery D; Biogen, Cambridge, Massachusetts, USA stephanie.licata@biogen.com.
  • Arnold DL; Piedmont HealthCare, Mooresville, North Carolina, USA.
  • Filippi M; Montreal Neurological Institute and Hospital, Montreal, Québec, Canada.
  • Geurts JJ; NeuroRx Research, Montreal, Québec, Canada.
  • Santra S; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Campbell N; Department of Anatomy and Neurosciences, Section of Clinical Neuroscience, VUmc MS Center Amsterdam, VU University Medical Centre Amsterdam, Amsterdam, The Netherlands.
  • Ho PR; Biogen (at the time of these analyses), Cambridge, Massachusetts, USA.
BMJ Open ; 10(10): e038861, 2020 10 20.
Article em En | MEDLINE | ID: mdl-33082194
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália